Arrayit Corporation (ARYC)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2014 | -3.31 Million USD | -768.2% |
| 2013 | -381.89 Thousand USD | -266.67% |
| 2012 | 229.13 Thousand USD | 215.29% |
| 2011 | -198.74 Thousand USD | 93.88% |
| 2010 | -3.24 Million USD | 63.54% |
| 2009 | -8.9 Million USD | -338.89% |
| 2008 | -2.02 Million USD | -456.03% |
| 2007 | 570.09 Thousand USD | 109.98% |
| 2006 | -5.71 Million USD | -30.43% |
| 2005 | -4.38 Million USD | 17.41% |
| 2004 | -5.3 Million USD | -23.43% |
| 2003 | -4.29 Million USD | -57.19% |
| 2002 | -2.73 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2015 Q3 | -3.15 Million USD | -621.07% |
| 2015 Q1 | -1.47 Million USD | 41.04% |
| 2015 Q2 | -437.73 Thousand USD | 70.29% |
| 2014 Q1 | 37.62 Thousand USD | 107.28% |
| 2014 FY | -3.31 Million USD | -768.2% |
| 2014 Q4 | -2.49 Million USD | -511.91% |
| 2014 Q3 | -408.36 Thousand USD | 8.44% |
| 2014 Q2 | -446 Thousand USD | -1285.54% |
| 2013 FY | -381.89 Thousand USD | -266.67% |
| 2013 Q4 | -516.63 Thousand USD | -1924.71% |
| 2013 Q1 | 235.47 Thousand USD | -79.0% |
| 2013 Q3 | 28.31 Thousand USD | 139.09% |
| 2013 Q2 | -72.42 Thousand USD | -130.76% |
| 2012 Q4 | 1.12 Million USD | 22643.7% |
| 2012 Q1 | -192.15 Thousand USD | -893.52% |
| 2012 FY | 229.13 Thousand USD | 215.29% |
| 2012 Q3 | 4931.00 USD | 108.33% |
| 2012 Q2 | -59.16 Thousand USD | 69.21% |
| 2011 Q4 | 24.21 Thousand USD | 127.55% |
| 2011 FY | -198.74 Thousand USD | 93.88% |
| 2011 Q2 | -130.16 Thousand USD | -2559.18% |
| 2011 Q3 | -87.89 Thousand USD | 32.48% |
| 2011 Q1 | -4895.00 USD | 99.23% |
| 2010 Q1 | -715.74 Thousand USD | 88.17% |
| 2010 FY | -3.24 Million USD | 63.54% |
| 2010 Q4 | -634.04 Thousand USD | -33.73% |
| 2010 Q3 | -474.1 Thousand USD | 66.71% |
| 2010 Q2 | -1.42 Million USD | -99.0% |
| 2009 FY | -8.9 Million USD | -338.89% |
| 2009 Q2 | 15.17 Million USD | 174.25% |
| 2009 Q4 | -6.05 Million USD | -351.64% |
| 2009 Q3 | 2.4 Million USD | -84.15% |
| 2009 Q1 | -20.43 Million USD | -1393.7% |
| 2008 Q3 | -289.85 Thousand USD | -1120.44% |
| 2008 FY | -2.02 Million USD | -456.03% |
| 2008 Q4 | -1.36 Million USD | -371.98% |
| 2008 Q1 | -201.37 Thousand USD | 89.42% |
| 2008 Q2 | 28.4 Thousand USD | 114.11% |
| 2007 Q1 | 590.1 Thousand USD | 122.83% |
| 2007 FY | 570.09 Thousand USD | 109.98% |
| 2007 Q4 | -1.9 Million USD | -602.88% |
| 2007 Q3 | -270.87 Thousand USD | -112.57% |
| 2007 Q2 | 2.15 Million USD | 265.15% |
| 2006 Q2 | -1 Million USD | -14.05% |
| 2006 Q3 | 1.79 Million USD | 278.21% |
| 2006 FY | -5.71 Million USD | -30.43% |
| 2006 Q4 | -2.58 Million USD | -244.24% |
| 2006 Q1 | -881.68 Thousand USD | -98.08% |
| 2005 Q1 | -1.9 Million USD | 31.32% |
| 2005 Q4 | -445.11 Thousand USD | 68.14% |
| 2005 Q3 | -1.39 Million USD | -121.23% |
| 2005 FY | -4.38 Million USD | 17.41% |
| 2005 Q2 | -631.44 Thousand USD | 66.88% |
| 2004 Q1 | -858.86 Thousand USD | 20.79% |
| 2004 Q4 | -2.77 Million USD | -328.63% |
| 2004 FY | -5.3 Million USD | -23.43% |
| 2004 Q3 | -647.66 Thousand USD | 36.53% |
| 2004 Q2 | -1.02 Million USD | -18.81% |
| 2003 Q1 | -1.12 Million USD | -183.96% |
| 2003 Q4 | -1.08 Million USD | 4.74% |
| 2003 Q3 | -1.13 Million USD | -19.79% |
| 2003 FY | -4.29 Million USD | -57.19% |
| 2003 Q2 | -950.19 Thousand USD | 15.45% |
| 2002 Q4 | -395.78 Thousand USD | 79.07% |
| 2002 Q1 | -250.3 Thousand USD | 0.0% |
| 2002 Q3 | -1.89 Million USD | 0.0% |
| 2002 FY | -2.73 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | -135.149% |
| Atlantic International Corp. | -5.62 Million USD | 41.083% |
| Biocept, Inc. | -32.08 Million USD | 89.667% |
| Bioqual, Inc. | 483.48 Thousand USD | 785.775% |
| CardioGenics Holdings Inc | -1.91 Million USD | -73.018% |
| DermTech, Inc. | -100.88 Million USD | 96.714% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 100.164% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | 84.646% |
| iMD Companies, Inc. | -200.63 Thousand USD | -1552.542% |
| IDenta Corp. | 14.64 Thousand USD | 22741.314% |
| Interpace Biosciences, Inc. | 802 Thousand USD | 513.416% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | 8669.862% |
| InVitro International | 1553.00 USD | 213596.072% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | 61.411% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -5605.524% |
| Medical Imaging Corp. | -3.02 Million USD | -9.678% |
| NovelStem International Corp. | -4.18 Million USD | 20.818% |
| Optigenex Inc. | -2.89 Million USD | -14.419% |
| PharmChem, Inc. | 845.1 Thousand USD | 492.331% |
| Proteome Sciences plc | -2.44 Million USD | -35.718% |
| Response Genetics, Inc | -20.18 Million USD | 83.573% |
| Rennova Health, Inc. | -3.29 Million USD | -0.684% |
| RushNet, Inc. | -607.02 Thousand USD | -446.201% |
| ScreenPro Security Inc. | -2.24 Million USD | -47.441% |
| Stella Diagnostics Inc. | -5.7 Million USD | 41.907% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | 70.955% |
| Todos Medical Ltd. | -24.99 Million USD | 86.734% |